LUCD Lucid Diagnostics Inc.
Healthcare$1.07+7.00%ClosedMarket Cap: $109.5M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
27.27
P/S
21.32
EV/EBITDA
-2.56
DCF Value
$-2.86
FCF Yield
-42.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
-40.0%
Operating Margin
-959.6%
Net Margin
-876.7%
ROE
-370.2%
ROA
-132.1%
ROIC
-159.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.3M | -47.1% | $-12.1M | $-13.9M | $— | — |
| Q4 null | $1.5M | -23.7% | $-14.0M | $-16.3M | $— | — |
| FY null | $4.7M | -60.3% | $-49.6M | $-58.0M | $— | — |
| Q3 null | $1.2M | -40.1% | $-11.8M | $-10.4M | $— | — |
| Q2 null | $1.2M | -53.5% | $-11.4M | $-4.4M | $— | — |
| Q1 null | $828.0K | -87.3% | $-12.5M | $-26.9M | $— | — |
| Q4 null | $1.2M | -79.2% | $-12.4M | $-11.5M | $— | — |
| FY null | $4.3M | -90.2% | $-46.1M | $-45.5M | $— | — |
| Q3 null | $1.2M | -43.7% | $-11.7M | $-12.4M | $— | — |
| Q2 null | $976.0K | -65.4% | $-11.2M | $-11.0M | $— | — |
| Q1 null | $1.0M | -65.4% | $-10.8M | $-10.6M | $— | — |
| Q4 2023 | $1.0M | -40.1% | $-11.5M | $-10.8M | $-0.26 | — |